Senior insider sale
Chief Operating Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$17.6K
4.57K shares
What this filing means
SWARTZ ROBIN plans to sell 4.57K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $17.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/10/2026ACC: 0001959173-26-000819
Officer· Chief Operating Officer
Since Feb 2022
4.57K
Shares to sell
$17.6K
Approx. market value
4.57K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/9/2026
4.57KTotal acquired4.57K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/9/2026 | Restricted Stock Vesting Compensation | 4.57K | — |
| Total | 4.57K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.57K
Market value
$17.6K
2/10/2026
Total
Units
4.57K
Value
$17.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/10/2026 | 4.57K | $17.6K | NASDAQ | Planned |
| Total | 4.57K | $17.6K | ||